Fujifilm Diosynth breaks ground on $300M biotech plant expansion near Texas A&M

SourceHouston Chronicle
Date Published10/26/2022
Author NameMarissa Luck
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name FUJIFILM Diosynth Biotechnologies U.S.A.
Parent companyFUJIFILM Holdings Corporation
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):150
Year reshoring announced:2022
Capital investment ($):300
Country(ies) from which reshored:Japan
City reshored to:College Station
State(s) reshored to:TX
If relevant, work nearshored to:-
Industry(ies):Chemicals, Medical Equipment & Supplies
Product(s) reshoredNvovax coronavirus vaccine, medical devices
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Skilled workforce availability/training, Under-utilized capacity
Government Incentive dollar amount:$1.5 million grant, tate’s Texas Enterprise Fund
Find Reshoring Articles